Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
145M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
+712K
-
Total reported value, excl. options
-
$243M
-
Value change
-
+$3.51M
-
Put/Call ratio
-
0.46
-
Number of buys
-
37
-
Number of sells
-
-24
-
Price
-
$5.17
Significant Holders of Annexon, Inc. - Common Stock, par value $0.001 (ANNX) as of Q4 2022
90 filings reported holding ANNX - Annexon, Inc. - Common Stock, par value $0.001 as of Q4 2022.
Annexon, Inc. - Common Stock, par value $0.001 (ANNX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
of 145M outstanding shares and own 32.44% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (4.89M shares), Alerce Investment Management, L.P. (4.41M shares), BVF INC/IL (3.78M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.63M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.55M shares), Redmile Group, LLC (3.5M shares), Fairmount Funds Management LLC (3.36M shares), VR Adviser, LLC (3.22M shares), FEDERATED HERMES, INC. (3.06M shares), and CITADEL ADVISORS LLC (1.87M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.